Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Exercise/Conversion of 27,000 TNGX shares, $140.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| Sep 3, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| Aug 5, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| Jul 2, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| Jun 3, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| May 5, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| Apr 17, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 38,460 | $200.0K |
| Apr 3, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 27,000 | $140.4K |
| Mar 28, 2026 | Tango Therapeutics, Inc. (TNGX) | Exercise/Conversion | 12,000 | $62.4K |
| Mar 9, 2026 | Tango Therapeutics, Inc. (TNGX) | Sale | 20,251 | $303.8K |